With the rise of innovative therapeutic modalities like CAR-Ts and vaccines, the need for efficient, purpose-built manufacturing technologies has never been greater.
Natalia highlighted how VIVEbiotech is incorporating cutting-edge solutions like AI and automation to enhance production efficiency and meet growing demand.
Don’t miss out on this insightful read: https://www.genengnews.com/topics/bioprocessing/vector-production-would-benefit-from-purpose-built-processing-technology/